JanolusimideCAS# 103612-45-9 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products

Cas No. | 103612-45-9 | SDF | Download SDF |
PubChem ID | 3037635 | Appearance | Powder |
Formula | C19H33N3O5 | M.Wt | 383.49 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S)-N-[(2S,3S,4R)-5-[(5S)-3,3-dimethyl-2,4-dioxo-5-propan-2-ylpyrrolidin-1-yl]-3-hydroxy-4-methyl-5-oxopentan-2-yl]-2-(methylamino)propanamide | ||
SMILES | CC(C)C1C(=O)C(C(=O)N1C(=O)C(C)C(C(C)NC(=O)C(C)NC)O)(C)C | ||
Standard InChIKey | WGXYHQKAYMMOTR-QMVSFRDZSA-N | ||
Standard InChI | InChI=1S/C19H33N3O5/c1-9(2)13-15(24)19(6,7)18(27)22(13)17(26)10(3)14(23)11(4)21-16(25)12(5)20-8/h9-14,20,23H,1-8H3,(H,21,25)/t10-,11+,12+,13+,14+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Janolusimide is a neurotoxin and atropine antagonist. |

Janolusimide Dilution Calculator

Janolusimide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6076 mL | 13.0381 mL | 26.0763 mL | 52.1526 mL | 65.1907 mL |
5 mM | 0.5215 mL | 2.6076 mL | 5.2153 mL | 10.4305 mL | 13.0381 mL |
10 mM | 0.2608 mL | 1.3038 mL | 2.6076 mL | 5.2153 mL | 6.5191 mL |
50 mM | 0.0522 mL | 0.2608 mL | 0.5215 mL | 1.0431 mL | 1.3038 mL |
100 mM | 0.0261 mL | 0.1304 mL | 0.2608 mL | 0.5215 mL | 0.6519 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland

TsingHua University

The University of Michigan

Miami University

DRURY University

Jilin University

Fudan University

Wuhan University

Sun Yat-sen University

Universite de Paris

Deemed University

Auckland University

The University of Tokyo

Korea University
- RETRA hydrochloride
Catalog No.:BCC2415
CAS No.:1036069-26-7
- 5,7-Dimethoxyflavanone
Catalog No.:BCN3569
CAS No.:1036-72-2
- Isookanin
Catalog No.:BCN6476
CAS No.:1036-49-3
- P005672 hydrochloride
Catalog No.:BCC6406
CAS No.:1035979-44-2
- Lansoprazole
Catalog No.:BCC1058
CAS No.:103577-45-3
- TAK-733
Catalog No.:BCC4587
CAS No.:1035555-63-5
- 3,7-O-Diacetylpinobanksin
Catalog No.:BCN5849
CAS No.:103553-98-6
- Huperzine B
Catalog No.:BCN1059
CAS No.:103548-82-9
- Apiosylskimmin
Catalog No.:BCN2455
CAS No.:103529-94-8
- AZD4547
Catalog No.:BCC3711
CAS No.:1035270-39-3
- AZ505 ditrifluoroacetate
Catalog No.:BCC4265
CAS No.:1035227-44-1
- AZ505
Catalog No.:BCC4264
CAS No.:1035227-43-0
- H-Phe(2-Cl)-OH
Catalog No.:BCC3165
CAS No.:103616-89-3
- (±)-5'-Chloro-5'-deoxy-ENBA
Catalog No.:BCC7716
CAS No.:103626-26-2
- Sumatriptan
Catalog No.:BCC5645
CAS No.:103628-46-2
- Sumatriptan Succinate
Catalog No.:BCC2502
CAS No.:103628-48-4
- Cnidimol A
Catalog No.:BCN7167
CAS No.:103629-80-7
- Catechin 3-rhamnoside
Catalog No.:BCN5850
CAS No.:103630-03-1
- Ondansetron hydrochloride dihydrate
Catalog No.:BCC4213
CAS No.:103639-04-9
- 2-Carbamoyl-3-hydroxy-1,4-naphthoquinone
Catalog No.:BCC8567
CAS No.:103646-20-4
- Mirificin
Catalog No.:BCN2783
CAS No.:103654-50-8
- Dihydrobonducellin
Catalog No.:BCN3731
CAS No.:103680-87-1
- YK-4-279
Catalog No.:BCC2065
CAS No.:1037184-44-3
- Rehmaglutin D
Catalog No.:BCN5851
CAS No.:103744-84-9
Isolation and stereospecific synthesis of janolusimide B from a New Zealand collection of the bryozoan Bugula flabellata.[Pubmed:25494238]
J Nat Prod. 2015 Mar 27;78(3):530-3.
NMR-directed screening of New Zealand marine organisms has led to the isolation of the modified tripeptide Janolusimide B from the common invasive bryozoan Bugula flabellata. The structure was established by NMR and MS analysis, degradative hydrolysis and derivatization, and stereoselective fragment synthesis. The bryozoan natural product is an N-methyl analogue of Janolusimide, previously reported from the Mediterranean nudibranch Janolus cristatus, a species known to prey upon bryozoa.